复旦张江：关于变更部分募集资金投资项目的公告

Core Viewpoint - Fudan Zhangjiang announced a change in its fundraising project, shifting from the "Heimofen American Registration Project" to the "Continuous Development Project for Innovative Photodynamic Drugs" [2] Group 1 - The eighth board meeting of the company will be held on October 30, 2025, to review the proposal for the change in fundraising projects [2] - The proposal requires approval from the company's shareholders' meeting [2]